Frequency, molecular pathology and potential clinical significance of partial chromosome 3 aberrations in uveal melanoma

Modern Pathology

Volumn 24, Issue 7, 2011, Pages 954-962

  Abdel Rahman, Mohamed H ^a   Christopher, Benjamin N ^a   Faramawi, Mohammed F ^b   Said Ahmed, Khaled ^a,c   Cole, Carol ^d   McFaddin, Andrew ^d   Ray Chaudhury, Abhik ^a   Heerema, Nyla ^a,d   Davidorf, Frederick H ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

^c MENOUFIA UNIVERSITY   (Egypt)

^d OHIO STATE UNIVERSITY   (United States)

Author keywords

eye neoplasms; molecular genetics; uveal melanoma

Indexed keywords

ADULT; AGED; ALLELIC IMBALANCE; ARTICLE; CHROMOSOME 3; CHROMOSOME ABERRATION; CHROMOSOME DELETION; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; CYTOGENETICS; FEMALE; FOLLOW UP; GENOTYPE; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MALE; METASTASIS; MICROSATELLITE MARKER; MOLECULAR PATHOLOGY; MONOSOMY; MONOSOMY 3; PARTIAL CHROMOSOME 3 ALTERATION; PATHOGENESIS; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; UVEA MELANOMA;

ADULT; AGED; AGED, 80 AND OVER; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 3; COMPARATIVE GENOMIC HYBRIDIZATION; FEMALE; GENOTYPE; HISTORY, 17TH CENTURY; HUMANS; KAPLAN-MEIER ESTIMATE; KARYOTYPING; MALE; MELANOMA; NEOPLASM INVASIVENESS; POLYMERASE CHAIN REACTION; UVEAL NEOPLASMS;

EID: 79959973290     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2011.51     Document Type: Article

References (29)

1. Damato B, Coupland SE. Translating uveal melanoma cytogenetics into clinical care. Arch Ophthalmol 2009;127:423-429.
2. Shields JA, Shields CL, Materin M, et al. Role of cytogenetics in management of uveal melanoma. Arch Ophthalmol 2008;126:416-419. (Pubitemid 351398468)
3. Prescher G, Bornfeld N, Hirche H, et al. Prognostic implications of monosomy 3 in uveal melanoma. Lancet 1996;347:1222-1225. (Pubitemid 26131850)
4. Scholes AG, Damato BE, Nunn J, et al. Monosomy 3 in uveal melanoma: correlation with clinical and histologic predictors of survival. Invest Ophthalmol Vis Sci 2003;44:1008-1011. (Pubitemid 36297813)
5. Patel KA, Edmondson ND, Talbot F, et al. Prediction of prognosis in patients with uveal melanoma using fluorescence in situ hybridisation. Br J Ophthalmol 2001;85:1440-1444. (Pubitemid 34032910)
6. Aalto Y, Eriksson L, Seregard S, et al. Concomitant loss of chromosome 3 and whole arm losses and gains of chromosome 1, 6, or 8 in metastasizing primary uveal melanoma. Invest Ophthalmol Vis Sci 2001;42:313-317. (Pubitemid 32121456)
7. White VA, Chambers JD, Courtright PD, et al. Correlation of cytogenetic abnormalities with the outcome of patients with uveal melanoma. Cancer 1998;83:354-359. (Pubitemid 28317816)
8. Harbour JW. Molecular prognostic testing and individualized patient care in uveal melanoma. Am J Ophthalmol 2009;148:823-829 e821.
9. Trolet J, Hupe P, Huon I, et al. Genomic profiling and identification of high-risk uveal melanoma by array CGH analysis of primary tumors and liver metastases. Invest Ophthalmol Vis Sci 2009;50:2572-2580.
10. Shields CL, Ganguly A, Materin MA, et al. Chromosome .3. analysis of uveal melanoma using fine-needle aspiration biopsy at the time of plaque radiotherapy in .140. consecutive cases. Trans Am Ophthalmol Soc 2007;105:43-52; discussion 52-43. (Pubitemid 352031818)
11. Damato B, Dopierala J, Klaasen A, et al. Multiplex ligation-dependent probe amplification of uveal melanoma: correlation with metastatic death. Invest Ophthalmol Vis Sci 2009;50:3048-3055.
12. Worley LA, Onken MD, Person E, et al. Transcriptomic versus chromosomal prognostic markers and clinical outcome in uveal melanoma. Clin Cancer Res 2007;13:1466-1471. (Pubitemid 46450436)
13. Onken MD, Worley LA, Person E, et al. Loss of heterozygosity of chromosome 3 detected with single nucleotide polymorphisms is superior to monosomy 3 for predicting metastasis in uveal melanoma. Clin Cancer Res 2007;13:2923-2927. (Pubitemid 46849567)
14. White JS, McLean IW, Becker RL, et al. Correlation of comparative genomic hybridization results of 100 archival uveal melanomas with patient survival. Cancer Genet Cytogenet 2006;170:29-39. (Pubitemid 44332561)
15. Cross NA, Ganesh A, Parpia M, et al. Multiple locations on chromosome 3 are the targets of specific deletions in uveal melanoma. Eye 2006;20:476-481.
16. Hughes S, Damato BE, Giddings I, et al. Microarray comparative genomic hybridisation analysis of intraocular uveal melanomas identifies distinctive imbalances associated with loss of chromosome 3. Br J Cancer 2005;93:1191-1196. (Pubitemid 41670705)
17. Parrella P, Fazio VM, Gallo AP, et al. Fine mapping of chromosome 3 in uveal melanoma: identification of a minimal region of deletion on chromosomal arm 3p25.1-p25.2. Cancer Res 2003;63:8507-8510. (Pubitemid 37549508)
18. Tschentscher F, Prescher G, Horsman DE, et al. Partial deletions of the long and short arm of chromosome 3 point to two tumor suppressor genes in uveal melanoma. Cancer Res 2001;61:3439-3442. (Pubitemid 32695038)
19. Parrella P, Sidransky D, Merbs SL. Allelotype of posterior uveal melanoma: implications for a bifurcated tumor progression pathway. Cancer Res 1999;59: 3032-3037. (Pubitemid 29315995)
20. Shields CL, Ganguly A, Materin MA, et al. Chromosome .3. analysis of uveal melanoma using fine-needle aspiration biopsy at the time of plaque radiotherapy in .140. consecutive cases. Arch Ophthalmol 2007;125: 1017-1024. (Pubitemid 47258031)
21. Devilee P, Cleton-Jansen AM, Cornelisse CJ. Ever since Knudson. Trends Genet 2001;17:569-573. (Pubitemid 32918298)
22. Skotheim RI, Diep CB, Kraggerud SM, et al. Evaluation of loss of heterozygosity/allelic imbalance scoring in tumor DNA. Cancer Genet Cytogenet 2001;127:64-70. (Pubitemid 32530096)
23. Cawkwell L, Bell SM, Lewis FA, et al. Rapid detection of allele loss in colorectal tumours using microsatellites and fluorescent DNA technology. Br J Cancer 1993;67:1262-1267. (Pubitemid 23172863)
24. Kallioniemi A, Krahu R, Kallioniemi O-P. Comparative genomic hybridization. In: Taylor GR (ed). CRC Press: Boca Raton, New York, London, Tokyo, 1997, pp 273-285.
25. Singh AD, Topham A. Survival rates with uveal melanoma in the United States: 1973-1997. Ophthalmology 2003;110:962-965. (Pubitemid 36560497)
26. Sisley K, Rennie IG, Parsons MA, et al. Abnormalities of chromosomes 3 and 8 in posterior uveal melanoma correlate with prognosis. Genes Chromosomes Cancer 1997;19:22-28. (Pubitemid 27193716)
27. Mensink HW, Vaarwater J, Kilic E, et al. Chromosome 3 intratumor heterogeneity in uveal melanoma. Invest Ophthalmol Vis Sci 2009;50:500-504.
28. Maat W, Jordanova ES, van Zelderen-Bhola SL, et al. The heterogeneous distribution of monosomy 3 in uveal melanomas: implications for prognostication based on fine-needle aspiration biopsies. Arch Pathol Lab Med 2007;131:91-96. (Pubitemid 46174141)
29. Sandinha T, Farquharson M, McKay I, et al. Correlation of heterogeneity for chromosome 3 copy number with cell type in choroidal melanoma of mixed-cell type. Invest Ophthalmol Vis Sci 2006;47:5177-5180. (Pubitemid 46723762)